E-LIB Suche - Ergebnisse für: Kim, Geoffrey

1

Landscape of cancer clinical trials in India – a comprehens..:

Gao, Peng ; Chen, Justin ; Hong, Zhongyu...
The Lancet Regional Health - Southeast Asia. 24 (2024) - p. 100323 , 2024

Link: https://doi.org/10.1016/..

2

Reimagining patient-centric cancer clinical trials: a multi..:

Li, Bob T. ; Daly, Bobby ; Gospodarowicz, Mary...
Nature Medicine. 28 (2022) 4 - p. 620-626 , 2022

Link: https://doi.org/10.1038/..

3

Decoding kinase-adverse event associations for small molecu..:

Gong, Xiajing ; Hu, Meng ; Liu, Jinzhong...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

4

Dose dependence of treatment-related adverse events for imm..:

Shulgin, Boris ; Kosinsky, Yuri ; Omelchenko, Andrey...
OncoImmunology. 9 (2020) 1 - p. , 2020

Link: https://doi.org/10.1080/..

5

Challenges and Opportunities in Dose Finding in Oncology an..:

Ji, Yan ; Jin, Jin Y. ; Hyman, David M...
Clinical and Translational Science. 11 (2018) 4 - p. 345-351 , 2018

Link: https://doi.org/10.1111/..

6

Clinical Development of Cancer Drugs in Combination With Ex..:

Walker, Amanda J. ; Kim, Hyun ; Saber, Haleh...
International Journal of Radiation Oncology*Biology*Physics. 98 (2017) 1 - p. 5-7 , 2017

Link: https://doi.org/10.1016/..

7

Enrollment of older adults on oncology trials: An FDA persp..:

Singh, Harpreet ; Beaver, Julia A. ; Kim, Geoffrey.
Journal of Geriatric Oncology. 8 (2017) 3 - p. 149-150 , 2017

Link: https://doi.org/10.1016/..

8

FDA ovarian cancer clinical trial endpoints workshop: A Soc..:

Herzog, Thomas J. ; Ison, Gwynn ; Alvarez, Ronald D....
Gynecologic Oncology. 147 (2017) 1 - p. 3-10 , 2017

Link: https://doi.org/10.1016/..

9

FDA Approval Summary: Atezolizumab for the Treatment of Pat..:

Ning, Yang-Min ; Suzman, Daniel ; Maher, V. Ellen...
The Oncologist. 22 (2017) 6 - p. 743-749 , 2017

Link: https://doi.org/10.1634/..

10

FDA Approval Summary: Nivolumab in Advanced Renal Cell Carc..:

Xu, James Xunhai ; Maher, V. Ellen ; Zhang, Lijun...
The Oncologist. 22 (2017) 3 - p. 311-317 , 2017

Link: https://doi.org/10.1634/..

11

21st Century Cardio-Oncology:

Sheng, Calvin Chen ; Amiri-Kordestani, Laleh ; Palmby, Todd...
JACC: Basic to Translational Science. 1 (2016) 5 - p. 386-398 , 2016

Link: https://doi.org/10.1016/..

12

U.S. Food and Drug Administration Approval Summary: Enzalut..:

Ning, Yang-Min ; Brave, Michael ; Maher, V. Ellen...
The Oncologist. 20 (2015) 8 - p. 960-966 , 2015

Link: https://doi.org/10.1634/..

13

Successes and Challenges of PARP Inhibitors in Cancer Thera..:

Ricks, Tiffany K. ; Chiu, Haw-Jyh ; Ison, Gwynn...
Frontiers in Oncology. 5 (2015) - p. , 2015

Link: https://doi.org/10.3389/..

14

Development of Systemic and Topical Drugs to Treat Non-musc..:

Jarow, Jonathan ; Maher, V. Ellen ; Tang, Shenghui...
Bladder Cancer. 1 (2015) 2 - p. 133-136 , 2015

Link: https://doi.org/10.3233/..

15

L‐asparaginase inhibits invasive and angiogenic activity an..:

Yu, Minshu ; Henning, Ryan ; Walker, Amanda...
Journal of Cellular and Molecular Medicine. 16 (2012) 10 - p. 2369-2378 , 2012

Link: https://doi.org/10.1111/..